425 related articles for article (PubMed ID: 25887489)
1. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
Cho SY; Lee DG; Choi SM; Park C; Chun HS; Park YJ; Choi JK; Lee HJ; Park SH; Choi JH; Yoo JH
BMC Infect Dis; 2015 Feb; 15():69. PubMed ID: 25887489
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Araoka H; Baba M; Okada C; Abe M; Kimura M; Yoneyama A
Int J Infect Dis; 2017 May; 58():18-21. PubMed ID: 28257816
[TBL] [Abstract][Full Text] [Related]
3. Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.
Watson L; Esterly J; Jensen AO; Postelnick M; Aguirre A; McLaughlin M
J Glob Antimicrob Resist; 2018 Mar; 12():104-106. PubMed ID: 28964955
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
5. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
6. In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates.
Karamanlıoğlu D; Dizbay M
Turk J Med Sci; 2019 Apr; 49(2):683-686. PubMed ID: 30866602
[TBL] [Abstract][Full Text] [Related]
7. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
10. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.
Micozzi A; Venditti M; Monaco M; Friedrich A; Taglietti F; Santilli S; Martino P
Clin Infect Dis; 2000 Sep; 31(3):705-11. PubMed ID: 11017819
[TBL] [Abstract][Full Text] [Related]
11. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
Kim SH; Cho SY; Kang CI; Seok H; Huh K; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Ann Hematol; 2018 Feb; 97(2):343-350. PubMed ID: 29138886
[TBL] [Abstract][Full Text] [Related]
12. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy.
Araoka H; Fujii T; Izutsu K; Kimura M; Nishida A; Ishiwata K; Nakano N; Tsuji M; Yamamoto H; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Transpl Infect Dis; 2012 Aug; 14(4):355-63. PubMed ID: 22283869
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
[TBL] [Abstract][Full Text] [Related]
14. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.
Garazi M; Singer C; Tai J; Ginocchio CC
J Hosp Infect; 2012 Jun; 81(2):114-8. PubMed ID: 22494851
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
[TBL] [Abstract][Full Text] [Related]
17. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
[TBL] [Abstract][Full Text] [Related]
19. Stenotrophomonas maltophilia bloodstream infections in adult recipients of umbilical cord blood transplantation.
Kimura M; Yamamoto H; Uchida N; Ogura S; Yamamuro R; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Wake A; Taniguchi S; Araoka H
Transplant Cell Ther; 2021 Mar; 27(3):269.e1-269.e7. PubMed ID: 33781536
[TBL] [Abstract][Full Text] [Related]
20. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.
Velázquez-Acosta C; Zarco-Márquez S; Jiménez-Andrade MC; Volkow-Fernández P; Cornejo-Juárez P
Support Care Cancer; 2018 Jun; 26(6):1953-1960. PubMed ID: 29307014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
